Manufacturing site not PQ-ready during dossier submission – preventing PQ suspension



Published on 29/01/2026

Ensuring Manufacturing Sites are PQ-Ready Before Dossier Submission

As the regulatory landscape evolves, the imperative for manufacturing sites to achieve WHO Prequalification (PQ) readiness before dossier submission has never been greater. Inspections revealing non-compliance or readiness issues can be a significant barrier, leading to potential delays, financial penalties, or suspension of PQ status. This playbook will provide a step-by-step guide for pharmaceutical professionals to quickly assess and align their manufacturing facilities and operations with PQ requirements.

In the following sections, we will outline actionable practices that enhance preparedness, effective containment strategies when issues arise, and robust documentation techniques that ensure inspection readiness. The goal is to empower QA, QC, Engineering, and Regulatory Affairs (RA) professionals to approach PQ readiness with competence and confidence, thus reducing the risk of non-compliance during dossier submissions.

Symptoms/Signals on the Floor or in the Lab

Identifying early indicators of non-compliance or operational inadequacies can

prevent larger issues during the PQ process. Symptoms can stem from various aspects of manufacturing and quality assurance. Some key signs include:

  • Inconsistent Product Quality: Variations in finished product attributes can suggest underlying quality system issues.
  • Frequent Deviations: High rates of documented deviations signal potential systemic weaknesses in processes or controls.
  • Inspection Findings: Any existing audit findings from previous inspections should be carefully evaluated for unresolved recommendations.
  • Inadequate Training Records: Evidence of insufficient employee training related to GMP compliance may equate to operational risks.

It is essential to maintain vigilance and regularly review KPIs and other performance metrics that align with PQ standards. Recognize that these signals must be documented and addressed promptly to maintain compliance and efficacy.

Likely Causes

Understanding potential causes for PQ readiness failure is critical for efficient resolution. These can be categorized broadly into six areas:

  • Materials: Substandard raw materials or unexpected variations in supplies can compromise product quality.
  • Method: Inadequate or outdated SOPs, or deviations from validated methods can lead to inconsistencies.
  • Machine: Equipment malfunctions, calibration failures, or lack of maintenance may impact manufacturing integrity.
  • Man: Insufficient training or inadequate personnel may result in non-compliance with established GMP standards.
  • Measurement: Uncalibrated measurement instruments can produce erroneous data affecting quality assurance processes.
  • Environment: Environmental factors such as temperature excursions or contamination events can lead to product failures.
Pharma Tip:  PQ dossier deficiency during inspection preparation – CAPA expectations for PQ approval

Each category should be assessed to identify the root causes effectively, allowing prioritization of corrective actions.

Immediate Containment Actions (first 60 minutes)

Implementing immediate containment actions is critical to limit the impact of non-compliance. Typically, the first hour is crucial; here are key steps:

  1. Verify Symptoms: Confirm the presence of symptoms noted earlier through data collection and visual inspections.
  2. Quarantine Affected Materials: If defects are evident, promptly quarantine all affected batch materials and products.
  3. Notify Relevant Teams: Inform production, QA, and regulatory teams to ensure cross-functional awareness and a coordinated response.
  4. Document Everything: Keep detailed records of actions taken and issues encountered to maintain inspection-ready documentation.
  5. Initiate Preliminary Investigation: Start an initial investigation to capture immediate findings and insights while systemic reviews begin.

Each step must be recorded meticulously, ensuring that appropriate evidence is available to support further investigation and communication with inspectors.

Investigation Workflow

Establishing an effective investigation workflow ensures that the issues identified are adequately analyzed and resolved. The following steps should be integrated into the workflow:

  • Gather Data: Collect all relevant documentation, including batch records, training logs, and previous audit findings.
  • Interview Staff: Engage relevant personnel to gather insights into the operational aspects that may have led to the deviation.
  • Analyze Data: Use statistical methods to analyze gathered data, identifying trends or anomalies that may suggest root causes.
  • Document Findings: Keep a detailed report of the investigation process, observable trends, and focus areas for further assessment.
  • Review Results with a Cross-Functional Team: Conduct a review meeting involving all stakeholders to ensure comprehensive comprehension and buy-in for further actions.

This detailed investigation process not only facilitates identifying non-compliance root causes but serves as evidence for the effectiveness of triage actions taken.

Root Cause Tools

Various root cause analysis tools can facilitate effective identification and resolution of issues. Below are three commonly used tools, and scenarios for their use:

Tool When to Use
5-Why Analysis Best suited for simple problems; involves asking “Why?” repeatedly to dig deeper into the root cause.
Fishbone Diagram Effectively used when exploring multiple potential causes; visualizes factors that can contribute to a problem.
Fault Tree Analysis Utilized for complex systems; helps in systematically identifying possible failures leading to undesirable events.
Pharma Tip:  API change not reported during inspection preparation – CAPA expectations for PQ approval

Choosing the appropriate tool depends on the complexity of the issue and resource availability. Document the rationale for the chosen tool and outcomes to enhance future reference.

CAPA Strategy

The Corrective and Preventive Action (CAPA) system should be an integral part of managing PQ readiness. A structured approach is essential for effective resolution:

  • Correction: Implement immediate fixes to address identified non-conformities quickly.
  • Corrective Action: Investigate root causes thoroughly, ensuring that permanent solutions are developed and implemented to prevent recurrence.
  • Preventive Action: Assess existing processes for potential risks to implement measures that reduce future recurrence likelihood.

Documentation should include actions taken, reviews conducted, and subsequent effectiveness checks, ensuring compliance with regulatory QMS standards.

Control Strategy & Monitoring

A robust control strategy coupled with real-time monitoring safeguards against quality lapses. Essential components include:

  • Statistical Process Control (SPC): Implement SPC for critical processes to track variations and maintain process stability.
  • Regular Sampling: Ensure representative sampling is practiced to consistently analyze product quality.
  • Alarms and Alerts: Set automated alerts for process deviations, triggering immediate responses and corrective actions.
  • Verification Techniques: Consistent reviews of processes and compliance checks help verify control strategy effectiveness.

Documentation of monitoring activities is crucial to substantiate compliance with PQ standards during inspections.

Related Reads

Validation / Re-qualification / Change Control Impact

Changes to any process, procedure, or equipment necessitate careful validation, re-qualification, and change control activities to ensure continued compliance. Key considerations include:

  • Determine the Impact: Assess how changes could affect product quality and compliance with PQ standards.
  • Conduct Validation Studies: Engage in necessary validation assessments to validate new configurations or processes.
  • Re-qualification as Needed: Implement re-qualification processes following major changes to ensure all systems align with PQ requirements.
  • Document Everything: Maintain detailed records of all validation activities to demonstrate compliance during inspections.

Ensuring changes are managed through an established quality management system (QMS) substantiates adherence to regulatory compliance expectations.

Inspection Readiness: What Evidence to Show

When preparing for inspections, having the right documentation readily available is essential. Focus should be directed towards:

  • Records: Maintain accurate records of deviations, CAPA activities, and root cause investigations.
  • Logs: Ensure production and quality control logs are up-to-date and reflect real-time operations.
  • Batch Documentation: Ensure comprehensive batch records are available, detailing all manufacturing processes and quality controls.
  • Deviation Reports: Keep organized deviation reports that show identification, investigation, and resolution for all significant findings.
Pharma Tip:  PQ dossier deficiency during inspection preparation – preventing PQ suspension

Being prepared with these documents not only enhances inspection readiness but also demonstrates the facility’s commitment to GMP compliance and continual improvement.

FAQs

What is WHO Prequalification (PQ)?

WHO PQ is a process that assesses the quality, safety, and efficacy of medicines, ensuring that they meet international standards for HIV/AIDS, malaria, and tuberculosis therapies.

What are the major symptoms of a manufacturing site not being PQ-ready?

Common symptoms include inconsistent product quality, frequent deviations, inadequate training, and past inspection findings.

How can immediate containment of issues be ensured?

Quarantine affected materials, verify symptoms, notify teams, and document all actions taken in the first 60 minutes.

Which root cause analysis tool is best for complex issues?

For complex issues, a Fault Tree Analysis is often more effective as it systematically evaluates multiple potential failure points.

What should be included in the CAPA documentation?

CAPA documentation should detail actions taken, root causes identified, effectiveness checks, and timelines for corrective actions.

How does statistical process control help in maintaining PQ readiness?

SPC helps track process variations, enabling early detection of deviations from established norms, thus ensuring product quality consistency.

What is the role of validation in PQ readiness?

Validation establishes that systems and processes consistently produce results that meet quality standards, vital for maintaining compliance.

How should changes in processes be managed?

Changes must undergo impact assessments, necessitate validation or re-qualification, and be documented through a robust change control system.

What documentation is crucial for inspection readiness?

Key documents include deviation reports, batch records, CAPA records, and quality logs, all reflecting compliance with established procedures.

How can deviation reports aid in future inspections?

Well-maintained deviation reports serve as a clear record of issues and resolutions, demonstrating a commitment to continuous improvement in quality management.

What measures can prevent recurrence of issues identified during inspections?

Implement comprehensive CAPA strategies, enhance training programs, and continuously monitor processes to ensure adherence to quality standards.

Why is cross-functional involvement crucial in PQ readiness?

Cross-functional involvement ensures diverse insights and collaborative problem-solving, enhancing the effectiveness of investigations and compliance measures.